It decreed that drug companies must pay a “user fee” each time they filed a New Drug Application (NDA). These funds would then be used to support the FDA’s drug division.
It decreed that drug companies must pay a “user fee” each time they filed a New Drug Application (NDA). These funds would then be used to support the FDA’s drug division.